Walleye Capital
VIR icon

Walleye Capital’s Vir Biotechnology VIR Stock Holding History

Walleye Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.96M Buy
665,584
+409,459
+160% +$3.26M 0.02% 697
2025
Q4 		$1.54M Buy
256,125
+117,295
+84% +$698K ﹤0.01% 2073
2025
Q3 		$793K Sell
138,830
-45,100
-25% -$231K ﹤0.01% 2276
2025
Q2 		$927K Sell
183,930
-67,036
-27% -$359K ﹤0.01% 2112
2025
Q1 		$1.63M Sell
250,966
-183,494
-42% -$1.63M 0.01% 1581
2024
Q4 		$3.19M Buy
434,460
+410,684
+1,727% +$3.24M 0.01% 1383
2024
Q3 		$178K Buy
+23,776
New +$207K ﹤0.01% 4086
2024
Q2 		– Sell
-172,656
Closed -$1.75M – 6043
2024
Q1 		$1.75M Sell
172,656
-11,168
-6% -$114K ﹤0.01% 2087
2023
Q4 		$1.85M Sell
183,824
-394,711
-68% -$3.61M ﹤0.01% 1852
2023
Q3 		$5.42M Sell
578,535
-284,845
-33% -$4.06M 0.01% 978
2023
Q2 		$21.2M Buy
+863,380
New +$21.7M 0.08% 152
2022
Q1 		– Sell
-5,100
Closed -$214K – 2618
2021
Q4 		$214K Buy
+5,100
New +$200K 0.01% 1432

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return